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Introduction
Distinct intracellular signaling pathways via activation of G protein-coupled receptors (GPCRs) are coupled to evoke distinct functional specificities in cells. Activation and inactivation of G proteins are highly regulated cellular events, and the regulator of G protein signaling (RGS) family of proteins are direct modulators of G protein activity. RGS proteins are extensively investigated as GTPase-activating proteins (GAPs) for heterotrimeric G protein Gα subunits. The proteins bind to the activated form of Gα and enhance its GTPase activity, thereby terminating Gα-dependent signaling [1] . Thus, RGS proteins reduce the maximal or steady-state levels of active G proteins and some RGS proteins also serve as effector antagonists to inhibit GPCR-mediated cellular signaling [1] .
The members of the RGS protein family share a conserved RGS domain of approximately 120 amino acids, which is necessary and sufficient for binding to Gα and their GTPase-activating GAP activities [2] . Other than the RGS domain, the >30 family members are widely divergent. RGS proteins are classified into at least six subfamilies based on RGS domain identities, and related subfamily members also share conserved regions outside of their RGS domains [2, 3] . Some RGS proteins, including members of the RA, R7 and R12 subfamilies, possess highly ordered structures with multiple functional domains. In contrast, the RZ and B/R4 subfamilies are simple, with relatively short featureless N-and C-terminal regions flanking the RGS domain. The RZ subfamily contains RGS17, 19 and 20, among which RGS19 was one of the first RGS proteins to be identified. The B/R4 subfamily contains the simplest RGS proteins. The members of this subfamily (RGS1, 2, 3, 4, 5, 8, 13 and 16) share a conserved amphipathic helix near their N-termini but have no other identifiable features outside of their RGS domains. These family members are often considered prototypical because they do not appear to have functions other than modulation of G protein activity.
By analyzing purified proteins in vitro, many RZ and B/R4 RGS proteins were found to nonselectively bind to and/or inhibit signaling by Gαo, Gαi, Gαz and Gαq [3] . However, subsequent studies revealed that some RGS proteins could function in living cells and selectively control the activities of specific G proteins. Furthermore, RGS proteins play roles beyond G protein regulation. It has been reported that RGS proteins can distinguish GPCRs that are coupled to the same G protein when expressed in a whole-cell assay system [1] [2] [3] . RGS19 has been shown to preferentially regulate the Gαi-coupled signaling of the ORL1 receptor over other opioid receptors [4] . RGS4 differentially inhibits signaling through Gαq-coupled muscarinic acetylcholine or cholecystokinin receptors in cells [5] . Electrophysiological analyses in Xenopus oocytes revealed that RGS8 decreased the response upon activation of Gαq-coupled M1 muscarinic acetylcholine receptor (mAChR) or substance P receptor, but did not remarkably inhibit the signaling from Gαq-coupled M3 mAChR [6] . Furthermore, RGS1, 2, 4 and 16 displayed different relative potencies of their inhibitory activities toward signaling from Gαq/11-linked muscarinic, bombesin or cholecystokinin receptors [7] . A separate study showed that RGS3, but not RGS1, 2 or 4, specifically inhibited gonadotropin-releasing hormone receptor-mediated inositol-1,4,5-triphosphate production in transfected COS cells [8] . Taken together, these results suggest that GPCRs possess intrinsic differential affinities for RGS proteins that determine their signaling functions. A recently discovered mechanism is that direct and selective interactions of RGS proteins with GPCRs are mediated through the receptor third intracellular (i3) loop [9] [10] [11] [12] or the C-terminal domain [12] . Interestingly, the N-termini of RGS2, 4, 8 and 19, which do not contain the RGS domain, are necessary for receptor-type specific inhibition of signaling [4, 5, [9] [10] [11] [12] .
However, further understanding of the molecular mechanisms between GPCRs and RGS proteins requires much more information based on evaluation of the different receptor type-specific attenuations mediated by RGS proteins.
The orexigenic cyclic 19-amino-acid peptide melanin-concentrating hormone (MCH) [13] is the natural ligand for the class A GPCR MCH-1 receptor (MCH1R) [14, 15] . The receptor is primarily expressed in the brain, where high expression of MCH1R mRNA is detected in the piriform cortex, olfactory tubercle, hippocampal formation, shell of the nucleus accumbens and amygdala [16] . A solid body of genetic and pharmacological evidence supports roles for MCH and MCH1R in the modulation of food intake and energy expenditure. Genetic ablation of both MCH [17] and MCH1R [18, 19] in mice produces animals that are both lean and resistant to diet-induced obesity. Other studies have indicated that acute and chronic administration of MCH enhances food intake and body weight [20] and that overexpression of MCH in transgenic mice leads to obesity and insulin resistance [21] .
Although a second MCH receptor (MCH2R) has also been identified [22] , its physiological role in these effects is unknown since genetic evidence indicates that mice do not express a functional form of this receptor [23] . High throughput screening efforts have led to the identification of small molecule MCH1R antagonists with diverse structural features and drug-like properties. In vivo results with these antagonists have indicated efficacy in several animal models of body weight regulation and feeding behavior [24] . Some of these antagonists also exhibit antidepressant and anxiolytic effects [25, 26] .
When expressed in heterologous cell lines, MCH1R is able to activate multiple signaling pathways, cyclic AMP inhibition, calcium mobilization and ERK through Gαi/o-and Gαq-coupled pathways [14, 15, 27] . Mutagenesis and deletion studies of MCH1R have demonstrated that the second intracellular (i2) loop in the BBXXB motif (in which B is a basic residue and X is a nonbasic residue) and the proximal region of the C-terminal tail have profound functions for intracellular signaling pathways [28, 29] . These observations suggest that there may be different determinants for modulating receptor-G protein activation. Recently, a yeast-two-hybrid approach identified MIZIP, periplakin and neurochondrin, which interact with the C-terminus of MCH1R [30] [31] [32] . Interaction of periplakin or neurochondrin with the proximal region of the C-terminus reduces the capacity of the receptor to initiate signaling. However, the mechanisms for how the GAP activity of MCH1R is modulated, and thus the mechanisms for how RGS proteins regulate MCH1R signaling, have not been examined and are largely unknown.
In the present study, we investigated whether there are direct physical interactions between RGS proteins and MCH1R that could dictate selectivity. In order to identify RGS proteins that interacted with MCH1R via its intracellular domains, we first focused on the i3 loop and generated GST fusion peptides of this domain to be used as affinity matrices for screening interacting RGS proteins in pull-down experiments. Our results demonstrated for the first time that (a) RGS8 in the B/R4 subfamily directly and selectively interacts with MCH1R via the i3 loop, (b) RGS8 suppresses MCH1R-mediated calcium mobilization in human embryonic kidney 293 (HEK293) cells, and the N-terminus of RGS8 mediates the functional interaction with the MCH1R-i3 loop, and (c) both Arg 253 and Arg 256 in the BBXXB motif of the i3 loop are functionally influential for the interaction with RGS8. Our data provide the first example that a specific RGS protein interacts directly with MCH1R.
Our results raise the possibility that RGS8 may have potential for therapeutic intervention in obesity.
Experimental procedures

DNA construction
The generation of a cDNA encoding a Flag epitope tag before the first methionine of rat MCH1R was described previously [28] . Flag-tagged rat MCH1R (Flag-MCH1R) was transfected into HEK293T cells to measure the receptor protein expression, surface expression and localization. Wild-type MCH1R and Flag-MCH1R have similar EC50 values for MCH [28] . Rat M1 mAChR was a gift from Dr. T. Haga (Gakushuin University, Tokyo, Japan). MCH1R N-terminus, i2 loop, i3 loop and C-tail constructs were originally cloned into the PGEX-4T-1 vector to encode fusion proteins with an N-terminal GST tag. Each receptor fragment was amplified by PCR as a BamHI/XhoI fragment from the corresponding region of the rat full-length receptor as follows: N-terminus, amino acids 213-260; i2 loop, amino acids 233-280; i3 loop, amino acids 283-334; C-tail, amino acids 317-353. The fragments were isolated and subcloned in-frame with an N-terminal glutathione S-transferase (GST) tag into the pGEX4-1 vector. The open reading frames of all PCR-generated constructs were verified by nucleotide sequence analysis. Hemagglutinin (HA)x3-tagged RGS2, 4, 8 and 19 were obtained from Missouri S&T cDNA Resource Center (Rolla, MO). RGS8 without an HA-tag was produced as described previously [6] .
Induction and purification of GST fusion proteins
GST-MCH1R fusion proteins (GST-MCH1R-N, GST-MCH1R-i2, GST-MCH1R-i3 and GST-MCH1R-C) were transformed into BL21(DE3) Escherichia coli. For each protein used, a single common batch of protein-bead complexes was generated and stored as aliquots at -80°C. The concentrations of bound proteins were determined by comparison of the Coomassie Brilliant Blue (CBB) staining intensities of the GST fusion proteins with known amounts of a protein standard (BSA). For experiments, the volume of beads used for each protein was adjusted to ensure that the same amount of total protein was used for binding interactions.
GST pull-down assays with HA-RGS proteins
HEK293T cell lysates expressing HA-RGS proteins were mixed with GST or GST-MCH1R-i3 bound to glutathione-Sepharose beads (10-50 µl) in harvest buffer with protease inhibitors. Equal amounts of GST fusion proteins (10 μg) were added as determined by CBB staining. The total reaction volume was 250 µl. Reactions were incubated by rotating overnight at 4°C. Beads were collected by centrifugation at 500 x g for 5 min at 4°C and sequentially washed four times with harvest buffer and once with harvest buffer without Triton X-100. Bound proteins were eluted from the beads by the addition of 2 x SDS sample buffer. The protein eluates were subjected to SDS-PAGE and electrotransferred to Hybond-P PVDF membranes (GE Healthcare UK Ltd.). The membranes were blocked with 5% skim milk in Tris-buffered saline containing 0.1% Tween 20 (TTBS) for 1 h, incubated with an anti-HA antibody (3F10; Roche Diagnostics) for 2 h at room temperature, washed four times with TTBS and incubated with horseradish peroxidase-conjugated goat anti-rat IgG (GE Healthcare UK Ltd.) for 1 h. After four washes with TTBS, the reactive bands were visualized using an enhanced chemiluminescence (ECL) system (GE Healthcare UK Ltd.). After blotting, the membranes were stripped and reprobed with an anti-GST antibody (Nacalai Tesque, Kyoto, Japan).
Expression and purification of recombinant RGS8 proteins
Histidine (His)x6-RGS8 and its variants were expressed and purified as previously described [11] , with some modifications. The His-tagged protein constructs were introduced into E. coli 
GST pull-down assays with His-RGS8
Assays for interactions between the GST-MCH1R-i3 loop and His-RGS8 proteins were performed as previously described [11] . Briefly, the GST-MCH1R-i3 fusion protein (2 μg) was mixed with the His-RGS8 protein (1 μg) in harvest buffer containing protease inhibitors and incubated overnight at 4°C on a rotator. After the overnight reaction, glutathione-Sepharose beads were added and incubated for 1 h at 4°C to recover the GST fusion proteins. Beads were collected by centrifugation and sequentially washed three times with harvest buffer and once with harvest buffer without Triton X-100.
Bound proteins were eluted from the beads by the addition of 2 x SDS sample buffer. Bound RGS proteins were detected by western blot analysis. After blotting with the anti-RGS8 antibody, the membranes were stripped and reprobed with an anti-GST antibody.
Mutagenesis of MCH1R
Single-substitution mutations of the i3 loop were produced by oligonucleotide-mediated site-directed mutagenesis using a Quickchange site-directed mutagenesis kit (Stratagene, La Jolla, CA) [28, 29] . All the mutations in the MCH1R cDNA sequence were confirmed by sequencing analysis. The mutated MCH1R cDNAs were excised by EcoRI and XhoI digestion and inserted into the pcDNA3.1 expression vector.
Cell culture and transfection
HEK293T cells in 6-well plates were transiently transfected with Flag-MCH1R with or without vector or RGS proteins (total amount, 1.0 μg/well). DNA was mixed with the LipofectAMINE PLUS transfection reagent (Invitrogen, Carlsbad, CA), and the mixture was diluted with OptiMEM (Invitrogen) and added to HEK293T cells. The transfected cells were cultured in DMEM containing 10% fetal bovine serum (FBS). For calcium influx assays and immunocytochemistry, the cells were plated on 96-well plates and coverslips, respectively, at 24 h after transfection and cultured for a further 24 h.
Western blotting analyses for RGS proteins and Flag-MCH1R expressed in HEK293T cells
To raise an antiserum against intact RGS8, rabbits were immunized with a keyhole limpet hemocyanin-conjugated synthetic peptide corresponding to residues 27-42 (N-terminal) of RGS8 using an immunization protocol as described previously [33] . ,000 x g for 1 h at 4°C, and the resulting supernatants were used as membrane preparations. The protein concentrations were determined using a BCA protein assay kit (Pierce). Aliquots of the total proteins were separated by SDS-PAGE and electrotransferred to PVDF membranes. After blocking, HA-RGS proteins and RGS8 on the membranes were detected using anti-HA and anti-RGS8 antibodies, respectively, followed by horseradish peroxidase-conjugated goat anti-rat or anti-rabbit IgG.
The reactive bands were visualized with ECL substrates and analyzed using Scion Image (Scion Corporation, Frederick, MD). After blotting with the anti-RGS8 antibody, the membranes were stripped and reprobed with an anti-actin antibody (Chemicon, International Inc., Temecula, CA) or anti-Gαq/11 antibody (a gift from Dr. H. Ueda, Gifu University, Gifu, Japan).
Immunofluorescence microscopy
Transiently transfected HEK293T cells were preincubated in Hanks-HEPES buffer (pH 7.5) for 1 h and then incubated with or without 1 μM MCH for 1, 3, 5 or 15 min. Next, the cells were fixed, permeabilized (0.05% Triton X-100 in PBS), blocked for 30 min and incubated with anti-Flag M2 and anti-RGS8 antibodies at 4°C overnight. The primary antibodies were detected using Alexa Fluor 488-conjugated goat anti-mouse IgG and Alexa Fluor 546-conjugated goat anti-rabbit IgG, respectively (both from Molecular Probes, Eugene, OR). Images were acquired using an FV1000 confocal microscope and imaging system (Olympus, Tokyo, Japan). Diego, CA).
Measurement of intracellular
Results
The MCH1R-i3 loop selectively associates with RGS8
MCH1R is highly expressed in the brain and responsible for feeding. Therefore, it seems to represent a promising target for anti-obesity treatments. Based on recent observations that RGS proteins can selectively inhibit signaling through different GPCRs [2, 3] , we hypothesized that some RGS proteins, which are highly expressed in the brain, interact selectively with MCH1R. To determine whether RGS proteins form stable complexes with MCH1R, we took advantage of an affinity binding pull-down assay that was previously used to identify binding partners for other GPCRs [9] [10] [11] . A fusion protein of GST with the i3 loop of MCH1R (GST-MCH1R-i3) or GST alone was expressed in bacteria and recovered by binding to glutathione-Sepharose beads. RGS proteins with N-terminal 3xHA tags (HA-RGS proteins) were transiently transfected into HEK293T cells. We selected RGS2, 4, 8 and 19 proteins for these experiments, since they are highly expressed in the brain [34] [35] [36] . Total cell lysates of these cells were incubated with equal protein amounts of the immobilized GST fusion protein or GST (Fig. 1A, Input) . After collection and washing of the beads, the bound proteins were eluted by the addition of SDS sample buffer. Samples were subjected to SDS-PAGE and immunoblotting with an anti-HA antibody to detect bound HA-RGS proteins. We found that HA-RGS8 interacted with GST-MCH1R-i3 but not with GST alone (Fig. 1A , Pull-down). RGS2 was previously reported to bind to the i3 loop of M1 mAChR and i3 loop of α1A-adrenergic receptor [10] , while RGS4 was found to bind to the i3 loop of M1 mAChR and i3 loop of receptor δ-opioid receptor [12] . However, HA-RGS2, 4 and 19 did not interact with GST-MCH1R-i3. Next, we examined whether MCH1R-i3 contained a selective interactive region for RGS8. GST fusion proteins of the N-terminus, i2 loop and C-terminal tail were unable to bind HA-RGS8 (Fig. 1B) . These results provide the first biochemical demonstration of a selective interaction between MCH1R and RGS8 through the i3 loop of MCH1R.
Our results indicated that RGS8 bound to the i3 loop of MCH1R in the HEK293T cell lysate, which contained native proteins involved in MCH1R signaling. Thus, the RGS8-MCH1R-i3 interaction in purified the protein using a nickel-nitrilotriacetic acid column (Fig. 1C) . We found that purified His-RGS8 bound to GST-MCH1Ri3 in a similar manner to the protein in the cell lysate in Fig. 1A .
Taken together, these results demonstrate that RGS8 binds directly and selectively to the i3 loop of MCH1R in the absence of other contributing factors.
Coexpression of RGS8 with MCH1R at the cell membrane
Next, we examined whether RGS8 associated with MCH1R at the same subcellular location when coexpressed in the same cell. When HEK293T cells were transfected with a plasmid encoding RGS8 alone, RGS8 was detected in the cytosol and plasma membrane by immunofluorescence microscopy ( Fig. 2, RGS8 only upper panel). Localization in the nucleus was also observed in some cells. In contrast, untransfected HEK293T cells incubated with an anti-RGS8 antibody showed no significant immunostaining. When Flag-MCH1R and RGS8 were coexpressed, they were found together at the plasma membrane. Colocalization of Flag-MCH1R and RGS8 in the plasma membrane was also observed when Flag-MCH1R and HA-RGS8 were cotransfected and immunostained with anti-Flag M2 and anti-HA antibodies. Since coexpression of Flag-MCH1R did not seem to significantly promote RGS8 relocation to the plasma membrane from the cytosol (Fig. 2, upper panel) , membrane-targeting factors intrinsic to RGS8 may exist [11] and this feature may be sufficient for its localization at the plasma membrane, as previously described for RGS2 and RGS4 [9, 37] . We further assessed the cellular amounts of RGS8 by immunoblotting with an anti-RGS8 antibody (Fig. 2, lower panel) . We compared the total amounts of RGS8 protein expressed in cells transfected with RGS8 with or without Flag-MCH1R. The intensities of the corresponding bands were quantified by imaging analysis, and the expression levels of the bands were found to be comparable (Fig. 2, left lower panel) . Indeed, the intensity of the band in cells cotransfected with RGS8 and Flag-MCH1R was 100.2 ± 13.7% (mean ± SEM of four independent experiments) when the value in cells transfected with RGS8 alone was set as 100%. The amounts of RGS8 in the membrane fractions also remained unchanged in the presence or absence of Flag-MCH1R in three separate experiments (92.6 ± 9.1% in cells cotransfected with RGS8
and Flag-MCH1R vs. 100% in cells transfected with RGS8 alone) (Fig. 2, right lower panel) . Thus, these results indicate that coexpression of Flag-MCH1R did not significantly affect the total cellular amounts of RGS8 or elicit translocation of RGS8 to the membrane fraction.
To examine the effects of receptor ligand binding and G protein activation, cells coexpressing MCH1R and RGS8 were stimulated with MCH. Addition of 1 μM MCH for various times (1, 3, 5 or 15 min) did not alter the association of RGS8 with Flag-MCH1R at the plasma membrane (Fig. 2, upper panel). Immunoblotting analysis showed that treatment with MCH for 1 min did not cause translocation of RGS8 to the membrane fraction in three separate experiments (95.4 ± 10.2% in the presence of MCH vs. 100% in the absence of MCH) (Fig. 2, right lower panel) .
Taken together, these findings indicate that RGS8 and MCH1R are both present at the plasma membrane when coexpressed in the same cell, and that their formation is independent of downstream signaling events.
RGS8 inhibits MCH1R-mediated calcium signaling
To assess the functional effects of RGS8 on cellular responses mediated by G proteins, we compared calcium mobilization mediated by MCH1R expressed with or without recombinant RGS8 in HEK293T cells. Representative curves are shown in Fig. 3 . Coexpression of RGS8 significantly blocked calcium signaling by MCH. Next, to determine whether a certain concentration of cellular RGS8 is required to inhibit G protein-dependent signaling, we transfected cells with graded amounts of the RGS8 plasmid (Fig. 3) , leading to the production of graded cellular amounts of RGS8 protein. MCH1R couples with multiple G proteins and activates diverse signal transduction pathways that include both cAMP inhibition and calcium influx facilitation [14, 15, 27] , while MCH2R exclusively couples with Gαq [22] . GPCRs are known to stimulate the activation of phospholipase Cβ (PLCβ) isoforms via either Gαq or Gβν dimers released from activated Gαo/i, whereas only Gαo/i-mediated consistent with previous reports [28, 29] . The EC50 value in PTX-treated cells was 9.0 ± 0.9 nM, whereas that in untreated cells was 2.1 ± 0.3 nM (mean ± SEM of three independent experiments), and the +PTX (Gαq-dependent response)/-PTX (Gαo/i-independent response) ratio was 4.30. These results indicate that both PTX-sensitive Gαi/o and PTX-insensitive Gαq mediate the mobilization of intracellular calcium in response to MCH, and that a large component of the calcium influx is dependent on Gαq activity rather than Gαi/o activity.
RGS8 was found to preferentially bind Gαo and Gαi3 using in vitro binding assays [34] . Despite its weak binding to Gαq protein, RGS8 showed Gαq-coupled responses in a cellular environment. Use of the Xenopus oocyte system to investigate the regulatory effects of RGS8 on the Gαq-coupled responses revealed that RGS8 decreased the responses upon activation of M1 mAChR or substance P receptor [6] . Therefore, we next examined whether the effectiveness of RGS8 in blocking calcium signaling was mediated by Gαq and/or Gαo/i in Flag-MCH1R-expressing cells. When cells transfected with 0.8 μg of RGS8 and 0.2 μg of Flag-MCH1R were pretreated with PTX, the EC50 value was 56.7 ± 4.7 nM. Since the EC50 value in PTX-treated cells transfected with Flag-MCH1R alone was 9.0 ± 0.9 nM, RGS8 inhibited MCH1R-mediated calcium signaling with a 6.3-fold higher EC50 value under conditions that blocked Gαo/i-mediated signaling. On the other hand, cells cotransfected with RGS8 and Flag-MCH1R without PTX treatment had a 19-fold higher EC50 value (Table 1) . If RGS8 only attenuated Gαq-mediated calcium signaling, the extent of inhibition should be nearly identical regardless of PTX treatment. Collectively, these results suggest that RGS8 inhibits MCH1R signaling by inhibiting the actions of both Gαq and Gαo/i.
Evidence for an interaction between the N-terminus of RGS8 and MCH1R
It has been shown that the N-terminal domains of RGS proteins are required to promote their associations with Gα subunits and GPCRs [4, 5, [9] [10] [11] . Therefore, we examined the capacity of the N-terminal portion of RGS8 to inhibit the signaling of Flag-MCH1R (Fig. 4) . RGS8S is a short isoform of RGS8, which arises due to alternative splicing of the RGS8 gene. The RGS8S cDNA encodes 7 unique N-terminal amino acids instead of the normal amino acids 1-9 of RGS8 (6), while the rest of RGS8S is the same as RGS8 (Fig. 4A) . We transiently transfected cells with Flag-MCH1R with or without RGS8S constructs, and also performed western blot analyses with an anti-RGS8
antibody to compare the amounts of RGS8S protein expression. Although similar amounts of the exogenous RGS proteins were expressed in the cells, RGS8S exhibited a 2.2-fold lower efficacy than RGS8 (Fig. 4B, Table 1 ). Since RGS8 and RGS8S only differ by 9 N-terminal amino acids, we tested the relative capacities of RGS8 and a truncated form of RGS8, ΔN9, which lacked the first 9 N-terminal amino acids. When the expression levels were identical, ΔN9 showed a similar reduction in activity to RGS8S (Table 1) . In separate assays, we compared the capacities of authentic RGS8 and ΔN9 to bind GST-MCH1R-i3 protein.
The level of binding of ΔN9 to GST-MCH1R-i3 was decreased by 33% (Fig. 4C) . Taken together, these data suggest that the N-terminal 9 amino acids of RGS8 are necessary for optimal inhibition of MCH1R function.
As described above, a previous study showed that RGS8 blocks M1 mAChR-mediated regulatory function in Xenopus oocytes, as evaluated by an increase in Ca 2+ -activated Cl -currents [6] . The assay system demonstrated the importance of the N-terminal 9 amino acids of RGS8 for M1 mAChR-specific suppression [11] . By using the HEK293T system, we tested the extents of inhibition of RGS8, RGS8S and ΔN9 on M1 mAChR-mediated functions stimulated by carbachol ( Table 1) .
Coexpression of RGS8 caused inhibition of M1 mAChR-induced calcium mobilization with a 15-fold higher EC50 value without significantly changing the maximum response, while RGS8S and ΔN9 only showed 2.8-and 2.6-fold higher EC50 values, respectively. Thus, deletion of the N-terminal 9 amino acids of RGS8 caused a more dramatic reduction in the potency of M1 mAChR-mediated signaling (5.6-fold lower) compared to that of Flag-MCH1R (2.2-fold lower). These results suggest that the requirement of the N-terminal 9 amino acids of RGS8 for receptor signaling is not identical between M1 mAChR and Flag-MCH1R.
To further understand the mechanism behind MCH1R inhibition by RGS8, we examined the roles of the RGS domain. A point mutation in the RGS domain of RGS8 (L153F) has been shown to greatly reduce the affinity for Gα and cause defective inhibition of G-protein signaling [38] . Therefore, we investigated how the L153F mutant affected Gαq signaling from Flag-MCH1R (Fig. 4B) . It was clearly found that the inhibition of Gαq signaling by L153F was quite weak, in comparison with the suppressive activity of RGS8. These data indicate that RGS8 is unable to suppress Gα-coupled signaling effectively without the intact GAP function of the RGS domain. Therefore, it is considered that both the N-terminal 9 amino acids and the RGS domain of RGS8 are necessary for the optimal capacity to attenuate Flag-MCH1R-mediated signaling.
The distal region of the MCH1R-i3 loop comprises a structurally important site for the interaction with RGS8
Since RGS8 directly associates with the i3 loop of Flag-MCH1R, we wondered which amino acid residues within the i3 loop were involved in altering this functional interaction. Saitoh et al. [11] reported that the C-terminus of the M1 mAChR-i3 loop is the specific site for RGS8 association. We previously created a variety of MCH1R mutants including a structural BBXXB motif. Therefore, we took advantage of our experience to select six substitution mutants in which the basic residues at the C-terminus of the i3 loop were replaced with neutrally charged glutamine residues. The levels of receptor expression of single-substitution (R248Q, K252Q, R253Q and R256Q), R253Q/R256Q and K252Q/R253Q/R256Q mutants were identical to that of Flag-MCH1R [29, 39] (Fig. 5A ). Previous radioligand binding experiments using cell membrane preparations revealed that the maximal binding capacity (Bmax) values of the single-substitution, R253Q/R256Q and K252Q/R253Q/R256Q mutants were similar to that of Flag-MCH1R, while the values of affinity constants (Kd) for the R253Q/R256Q
and K252Q/R253Q/R256Q mutants were decreased by 2-and 3-fold, respectively [29] . Regarding stimulation of a calcium influx, R248Q and K252Q had almost no effect [30, 39] , whereas both R253Q and R256Q caused approximately 4-fold increases in the EC50 values (Table 2 ) [29] . For R253Q/R256Q and K252Q/R253Q/R256Q, the apparent EC50 values of MCH were increased by 28-and 50-fold, respectively, while these mutant receptors showed similar maximal responses to MCH1R (Table 2 , Fig. 5A ) [29] .
Each receptor mutant was transiently transfected into cells alone or in combination with RGS8 and assayed for MCH-stimulated calcium mobilization. The levels of receptor expression and RGS8 expression were determined by immunoblotting analyses of the transfected cells using anti-Flag M2
and anti-RGS8 antibodies, respectively (Fig. 5A) . Coexpression of RGS8 did not significantly affect the amounts of R253Q/R256Q and K252Q/R253Q/R256Q. Similarly, the amounts of RGS8 were equivalent between R253Q/R256Q-and K252Q/R253Q/R256Q-expressing cells.
As shown in Table 2 and Fig. 5B inhibition of the receptor functional responses. Next, we examined whether the functional enhancement of RGS8 with the R253Q/R256Q mutant was correlated with an increase in the binding between them. For this purpose, the MCH1R mutant construct was expressed as a GST fusion protein containing the R253Q/R256Q mutations. Purified His-RGS8 protein was incubated with the GST fusion protein and subjected to a pull-down assay. His-RGS8 protein bound the GST fusion protein containing the R253Q/R256Q mutations with a similar affinity to its affinity for the GST fusion protein containing the non-mutated i3 loop (Fig. 5C) . Thus, the increase in RGS8 inhibition of the R253Q/R256Q receptor functional responses was not simply caused by an increase in binding between RGS8 and the GST-i3-R253Q/R256Q loop. These results show that Arg 253 and Arg 256 in the basic motif of the i3 loop comprise a structurally important site for functional interaction with RGS8 in the context of a cellular environment.
Discussion
In the present study, we have identified RGS8 as a negative modulator of MCH1R-mediated signaling. First, we found that RGS8 selectively and directly interacted with MCH1R via the receptor i3 loop. This interaction also occurred in living cells. MCH1R-mediated calcium mobilization was markedly attenuated by RGS8 through Gαq and Gαo/i-mediated pathways in HEK293T cells. The inhibition by RGS8 was dose-dependent, since higher expression levels of RGS8 further reduced the efficacy to induce calcium mobilization. Next, we examined which region is functionally important for the RGS8-MCH1R interaction, and found that both the N-terminal 9 amino acids and the RGS domain of RGS8 were involved in effective attenuation of the signaling evoked by MCH1R. Further analyses with site-directed mutagenesis of the i3 loop of MCH1R were performed in combination with RGS8.
This approach revealed that simultaneous mutations of Arg 253 and Arg 256 located at the C-terminus of the i3 loop increased RGS8 antagonist activity. To date, only the proximal C-terminus of MCH1R has been identified as being involved in binding to other functional molecules [31, 32] . Therefore, our present data provide the first evidence that the proximal region of the i3 loop in addition to the C-terminus is a protein-binding site that changes the receptor function.
There is growing evidence from a variety of functional assay systems that the N-terminal domains of RGS proteins are involved in GPCR-selective inhibition, whereas the conserved RGS domains act as GAPs [4, 5, [9] [10] [11] 40] . It therefore seemed likely that the affinities of the N-terminal domains of RGS proteins for particular GPCRs are critical for controlling the specificity and high-potency inhibition of receptor-coupled signaling in intact cells [3, 9] . However, a few reports have addressed the possibility of direct interactions of the N-terminal domains of RGS proteins with GPCRs in cellular environments [5, [9] [10] [11] 40] . B/R4 RGS proteins have been proposed to contain an N-terminal amphipathic helix that seems to be important for proper plasma membrane association [1, 2] . In the case of RGS2, the first 78 N-terminal amino acids are required for its association with M1 mAChR and α1A-adrenergic receptor and inhibition of their signaling [9, 10] . A recent study showed that RGS2 contains unique hydrophobic residues adjacent to the core amphipathic helix domain that are responsible for increased functions toward M1 mAChR [40] . RGS8 also blocks M1 mAChR-mediated regulatory functions in Xenopus oocytes by increasing Ca 2+ -activated Cl -currents [6] . It has been shown that deletion of the N-terminal and thus reduces its capacity to inhibit M1 mAChR-mediated signaling in Xenopus oocytes [11] . The functional importance of the N-terminal 9 amino acids of RGS8 was confirmed in our mammalian system, in which M1 mAChR-mediated signaling was monitored by calcium mobilization in receptor-transfected HEK293T cells. On the other hand, we found that the same 9 amino acids of RGS8 were also important for association with MCH1R and modulation of its signaling. However, ΔN9 had a more severe effect on M1 mAChR signaling (5.6-fold decrease) than on Flag-MCH1R signaling (2.2-fold decrease). These findings are roughly consistent with the results of in vitro pull-down assays with GST fusion proteins, since the binding of His-ΔN9 to M1 mAChR-i3 was drastically reduced by more than 80% compared with full-length RGS8 [11] , while the binding of
His-ΔN9 to MCH1R-i3 was reduced by 33%. These results indicate that the contact site in RGS8 for the MCH1R-i3 loop includes the N-terminal 9 amino acids, although the affinities of these amino acids differ for the MCH1R-i3 and M1 mAChR-i3 loops. It remains unclear which sites in RGS8 produce the key regulatory specificities toward MCH1R. By predicting secondary models and creating chimeras with other RGS proteins [38, 40] , the regions of RGS8 that are selective and sufficient for binding to MCH1R and for displaying RGS8 antagonist activity toward MCH1R will be clarified.
Unlike characterization of the receptor-binding sites within RGS proteins, only a few studies have addressed the issue of which regions in GPCRs are involved in associations with RGS proteins. It has been shown that the RGS-binding sites within GPCRs are located in the i3 loop [9] [10] [11] [12] and/or the C-terminus [12] . Both RGS2 and RGS4 have been reported to bind to the M1 mAChR-i3 loop, but their binding sites within the i3 loop have not been characterized. On the other hand, it has been shown that RGS8 can interact with the C-terminus of the M1 mAChR-i3 loop [11] . Moreover, the RGS2-binding site was found to be located in the N-terminal proximal half (Lys
219
, Ser 220 and Ser
238
) of the α1A-adrenergic receptor-i3 loop, since mutations of these residues led to a loss of binding with the receptor and resulted in decreased RGS2-mediated inhibition of receptor functional responses [10] .
In contrast, our mutations in the BBXXB motif at the C-terminus of the MCH1R-i3 loop accelerated RGS8 antagonist activity, and caused a loss of calcium mobilization by MCH.
A number of mutagenesis approaches have implied that the i3 loop is an important signaling structure in the GPCR superfamily. In particular, a BBXXB motif at the end of the i3 loop and into the N-terminus of transmembrane domain 6 has been shown to regulate GPCR activities, since mutations in this region can disrupt receptor coupling to G proteins or lead to constitutive activation of the receptors [41, 42] . We previously examined the functional role of the BBXXB motif in the i3 loop of MCH1R [28] . We found that the K252Q/R253Q/R256Q and R253Q/R256Q mutants in the motif still In summary, the present study has demonstrated that RGS8 is a negative modulator of MCH1R-mediated calcium signaling. MCH1R is a well validated target for potential therapeutic intervention in obesity. It is highly expressed in the brain, including the olfactory tubercle, hippocampal formation, nucleus accumbens and amygdala [16] . On the other hand, RGS8 is highly expressed in brain areas such as the cerebellum, olfactory tubercle, hippocampal formation and nucleus accumbens [34, 35] . Finding evidence for MCH signaling modulation by RGS8 in the olfactory tubercle, hippocampal formation and nucleus accumbens is of particular interest, since these regions are important in olfaction/feeding and motivated behavior/feeding. Studies of RGS proteins have provided insights into disease pathways, such as the contributions of RGS2 to hypertension and RGS4/RGS9-2 to drug addiction [3, 43] . Similarly, regulation by RGS8 may represent a new avenue for research into the mechanisms of MCH1R regulation in the nervous system and may lead to the development of novel drugs for treating disorders where modulation of MCH1R activity has therapeutic potential. subdomain-GST fusion protein was adjusted to 0.2 μg. C, RGS8 binds directly to the MCH1R-i3 loop.
6xHis-RGS8 was expressed in E. coli and purified by nickel-nitrilotriacetic acid affinity chromatography. Purified His-RGS8 (1 µg) was incubated with 2 µg of GST-MCH1R-i3 or GST alone and bound to glutathione-Sepharose beads. The beads were processed as described for (A), and the 
